Opto Biosystems Company Research Report

Company Overview

• Name: Opto Biosystems

• Mission: Developing tiny neural implants to track and treat the world's most difficult diseases, specifically targeting aggressive cancers by uniting cancer neuroscience and bioelectronic medicine.

• Founded: No information is available.

• Key People:

• Dr. Elise Jenkins - CTO & Co-Founder

• Dr. Ben Woodington - CEO & Co-Founder

• José Lepe - Head of Product

• Dr. Sagnik Middya - Microfabrication Engineer

• Isabel Dziuba - Biomedical Engineer

• Dr. Marcel Braendlein - Microfabrication Engineer

• Tanmay Burde - R&D Engineer

• Dr. Jake Stroud - Lead Computational Neural Scientist

• Dr. Emma Brunton - Neuroengineer

• Dr. Laura Mediavilla-Santos - Neural Data Scientist

• Caterina Azais - Biomedical Engineer

• Headquarters: Cambridge, UK

• Number of Employees: No information is available.

• Revenue: No information is available.

• Known For: Opto Biosystems is known for its groundbreaking work in developing neural interfaces within oncology, aiming to revolutionize cancer treatment through electrotherapies.

Products

SOMA-1

• Description: SOMA-1 is a new class of implantable device designed to measure and disrupt electric fields within the body. It is intended to offer new real-time biomarkers and diagnostic insights.

• Key Features:

• Electrical stimulation capabilities aimed at aggressive disease treatment.

• Electrical recording for real-time biomarkers.

Neurotechnology Platform

• Description: Opto’s platform is designed for treating brain cancers like glioblastoma with high coverage neural interfaces.

• Key Features:

• Smaller: Utilizes novel electrode materials and cutting-edge manufacturing for a compact, minimally invasive design.

• Softer: Integrates ultra-flexible materials mimicking biological tissue for better body conformity.

• Wireless: Employs high-bandwidth optical communication for discreet size and low power usage.

• Personalized Insights: Uses machine learning to derive neural biomarkers for individualized treatment efficacy, allowing for real-time electrophysiological mapping.

Recent Developments

• New Technology Application: Opto Biosystems has developed a new neurotechnology platform that reimagines neural interfaces for oncology treatments.

• Product Launches: No information is available on specific product launches.

• New Features Added: The newly built platform features heightened electrode coverage, ultra-flexible material design, novel electrode materials, batteryless operation, and advancements in wireless, optical communication.

• Partnerships: No information is available.

---

Contact Information:
Email: hello@opto.bio

Copyright: © 2024 Opto Biosystems | All rights reserved.